跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ANTHELIOS AGE CORRECT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ANTHELIOS AGE CORRECT
Authorized
STANDARD
ANTHELIOS AGE CORRECT
laboratoires la roche-posay canada
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b2782dc8d397d91f
Company
laboratoires la roche-posay canada
Type
Standard
Approval Details
Approval Id
b2782dc8d397d91f
Drug Approval Canada Name
ANTHELIOS AGE CORRECT
Product Name
ANTHELIOS AGE CORRECT
Status
Marketed
Status Date
2023-05-01
Original Market Date
2023-05-01
Din
02527812
Drug Class
Human
Dosage Form
Cream
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:80.00
Atc Original
D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Atc Name
d 02 ba 30
Aig Number
0663801001
Company Name
laboratoires la roche-posay canada
Company Address
4895 Hickmore, Montreal, Quebec, Canada, H4T 1K5
Active Ingredients
AVOBENZONE
2.3 % / W/W
DROMETRIZOLE TRISILOXANE
1.3 % / W/W
BEMOTRIZINOL
3.8 % / W/W
OCTISALATE
5 % / W/W
ENSULIZOLE
3.5 % / W/W
TEREPHTHALYLIDENE DICAMPHOR SULFONIC ACID
1 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b2782dc8d397d91f
Type
Standard
Back to Health Canada Approvals
